Shanghai Reborn Health Management Consultation Co., Ltd.

Reborn Health, officially known as Shanghai Reborn Health Management Consultation Co., Ltd., is a prominent clinical research service provider in China specializing in site management organization (SMO) and patient recruitment services. Founded in 2011, the company has established an extensive network covering over 500 clinical trial sites across mainland China, focusing on oncology, infectious diseases, and chronic conditions. In June 2021, Reborn Health was acquired by Novotech, a leading Asia-Pacific biotech specialist CRO, to enhance Novotech's clinical trial footprint and recruitment capabilities within the Chinese market. The company provides critical infrastructure and personnel to hospitals and clinical sites, ensuring high-quality data collection and efficient enrollment for pharmaceutical and biotechnology clients. Reborn Health operates as a key subsidiary of Novotech, facilitating cross-border clinical trials for international sponsors seeking to enter the Chinese healthcare ecosystem.